# DLBS1449 in Diabetic Patients With Low HDL

> **NCT01972477** · PHASE2,PHASE3 · WITHDRAWN · sponsor: **Dexa Medica Group**

## Conditions studied

- Diabetic Patients
- Low HDL-cholesterol (< 35 mg/dL)
- Lifestyle Intervention for at Least 1 Month

## Interventions

- **DRUG:** DLBS1449
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01972477
- **Lead sponsor:** Dexa Medica Group
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-07
- **Primary completion:** 2017-10
- **Final completion:** 2018-01
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2016-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01972477

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01972477, "DLBS1449 in Diabetic Patients With Low HDL". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01972477. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*